Jeffrey Jacobson REFERENCE:47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007 JEFFREY JACOBSON, Drexel University College of Medicine, Philadelphia Cou
Jeffrey Jacobson
REFERENCE:47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007JEFFREY JACOBSON, Drexel University College of Medicine, PhiladelphiaCould a monoclonal antibody have a role to play in HIV treatment? Early data on the PRO 140 antibody, presented at ICAAC, show that it does give responses. Derek Thorne discussed this news approach withJeffrey Jacobsonof Drexel University College of Medicine, Philadelphia.
Related Episodes
Which HIV Treatment is Best for Patients with HIV and Hepatitis C?
Juan Berenguer REFERENCE: Abstract V-1385, 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007 JUAN BERENGUER, Hospital Gregorio Marañón, Madrid A ret
Broad Approach, Including Computer System, to Improve Hospital Hygiene
Yehuda Carmeli REFERENCE: Abstract K-1373, 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007 YEHUDA CARMELI, Tel-Aviv Medical Center Hospitals can pre
DUET 1 and 2 Trials: TMC 125 has Superior Virologic and Immunologic Response Rates
Pedro Cahn REFERENCE: Abstract H-717, 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007 PEDRO CAHN, Juan A. Fernández Hospital, Buenos Aires Etraviri